ATYR
aTyr Pharma, Inc.
0.3376$
-10.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 60.2% | 93.1% | 80.0% | 75.5% | 92.9% | 97.3% | 96.3% | 88.2% | 91.7% | 98.3% | 84.4% | 85.4% | 84.6% | 85.2% | |
| 49.2% | 91.6% | 67.3% | 40.9% | 47.7% | 23.6% | 43.5% | 25.5% | 43.8% | 2.0% | 10.4% | 18.7% | 11.4% | 11.4% | |
| 49.2% | 91.6% | 76.8% | 73.7% | 89.6% | 95.3% | 93.9% | 86.1% | 81.8% | 93.4% | 69.1% | 81.4% | 74.5% | 83.6% | |
| – | – | – | – | – | – | – | 0.3% | 5.3% | 0.4% | 12.3% | 2.0% | 1.8% | 0.9% | |
| 116.9% | 266.1% | 540.9% | 11.3% | 22.0% | 28.1% | 36.2% | 41.9% | 18.7% | 5.5% | 25.6% | 25.0% | 27.9% | 28.5% | |
| 47.3% | 13.1% | 49.0% | 9.4% | 10.6% | 11.6% | 20.5% | 35.7% | 15.1% | 5.2% | 14.5% | 13.6% | 15.5% | 16.1% | |
| 11.7% | 1.8% | 24.9% | 2.6% | 0.4% | 5.6% | 14.7% | 26.2% | 2.2% | 0.8% | 0.9% | 1.1% | 1.3% | 1.6% | |
| 7.9% | 2.7% | 6.9% | 3.0% | 3.2% | 2.5% | 2.0% | 2.3% | 3.7% | 0.9% | 3.2% | 2.9% | 4.5% | 4.1% | |
| -17.2% | -172.2% | -440.9% | 88.7% | 78.0% | 71.9% | 63.8% | 58.5% | 81.7% | 94.6% | 74.6% | 75.1% | 72.3% | 71.7% | |
| -864.1% | -215.7% | -533.6% | -121.9% | -268.2% | -295.7% | -566.3% | -890.6% | -874.2% | -322.2% | -436.0% | -387.9% | -549.5% | -643.7% | |
| 528.0% | 0.1% | 0.3% | 0.9% | 2.1% | 2.1% | 4.1% | 9.3% | 23.7% | 16.5% | 29.7% | 44.4% | 76.7% | 98.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.